Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
2.110
-0.010 (-0.47%)
At close: Jan 22, 2025, 4:00 PM
2.100
-0.010 (-0.47%)
Pre-market: Jan 23, 2025, 8:03 AM EST
Immuneering Market Cap
Immuneering has a market cap or net worth of $65.52 million as of January 23, 2025. Its market cap has decreased by -66.94% in one year.
Market Cap
65.52M
Enterprise Value
19.10M
1-Year Change
-66.94%
Ranking
Category
Stock Price
$2.11
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $65.52M, a decrease of -82.09%. That is a compound annual growth rate of -38.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 65.83M | -3.64% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.91B |
| UnitedHealth Group | 478.29B |
| Novo Nordisk | 360.47B |
| Johnson & Johnson | 349.76B |
| AbbVie | 299.00B |
| Merck & Co. | 242.04B |
| Thermo Fisher Scientific | 219.78B |
| Intuitive Surgical | 217.43B |